Major Shareholder Boosts Stake as Zivo Bioscience Relocates Headquarters Director Laith Yaldoo acquired over $176,000 in Zivo Bioscience shares, raising his total holdings to 554,626 shares. The company also moved its main office to Troy, Michigan, and raised $1.5 million through new equity sales. These actions reflect both insider confidence and ongoing financial restructuring at the biotech firm.34